Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (HSAA)

Details for Australian Patent Application No. 2008338594 (hide)

Owner SciClone Pharmaceuticals, Inc.

Inventors Tuthill, Cynthia W.; Rios, Israel

Agent Wrays

Pub. Number AU-A-2008338594

PCT Pub. Number WO2009/079338

Priority 61/013,808 14.12.07 US

Filing date 11 December 2008

Wipo publication date 25 June 2009

International Classifications

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

24 June 2010 PCT application entered the National Phase

  PCT publication WO2009/079338 Priority application(s): WO2009/079338

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008338597-Multiple layer multifocal composite lens

2008338591-Binding molecules to the human OX40 receptor